New study reveals gaps in care for blood Thinner-Related brain bleeds

NCT ID NCT06420011

Completed Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 26 times

Summary

This study reviewed medical records of 123 adults hospitalized with a brain bleed while taking a common type of blood thinner (factor Xa inhibitor). Researchers collected data on patient characteristics, treatments, and outcomes to better understand the problem and improve future care. The study did not test a new treatment but aimed to gather real-world information.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRACRANIAL HAEMORRHAGE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Research Site

Buenos Aires, Argentina
Research Site

Joinville, Brazil
Research Site

Porto Alegre, Brazil
Research Site

Bogotá, Colombia
Research Site

Mexico City, Mexico
Research Site

Doha, Qatar
Research Site

Mecca, Saudi Arabia
Research Site

Riyadh, Saudi Arabia
Research Site

Abu Dhabi, United Arab Emirates
Research Site

Al Ain City, United Arab Emirates

Conditions

Explore the condition pages connected to this study.

INTRACRANIAL HAEMORRHAGE